Skip to main content

Table 1 Participant demographic characteristics (n = 43)

From: Type 2 diabetes and cardiometabolic risk may be associated with increase in DNA methylation of FKBP5

Characteristic Percentage or mean (standard deviation)
Sex (%)
 Female 48.8% (n = 21)
Race (%)
 Non-Hispanic White 37.2% (n = 16)
 Non-Hispanic Black 60.5% (n = 26)
 Asian 2.3% (n = 1)
Age (years) 61.9 ± 9.0
WC (cm) 109.7 ± 21.6
WC ≥ 94 cm (men) or 80 cm (women) (%) 81.5% (n = 35)
BMI (kg/m2) 34.1 ± 8.3
Antihypertensive medication use (%) 100% (n = 43)
HbA1c (%) 8.3 ± 1.6
LDL cholesterol (mg/dL) 89 ± 40
Cardiovascular procedure (%)*
 Catheterization 11.6% (n = 5)
 Percutaneous coronary intervention (PCI) 4.7% (n = 2)
 Coronary artery bypass surgery (CABG) 7.0% (n = 3)
 PCI and CABG 4.7% (n = 2)
  1. *Collectively this represents the total number of individuals included in the FKBP5 analysis model with a history of cardiovascular procedures (n = 12)